137 related articles for article (PubMed ID: 33665869)
61. Extracorporeal photopheresis efficiently impairs the proinflammatory capacity of human 6-sulfo LacNAc dendritic cells.
Gerner M; Hölig K; Wehner R; Zhao S; Schäkel K; Bachmann MP; Rieber EP; Bornhäuser M; Schmitz M
Transplantation; 2009 Apr; 87(8):1134-9. PubMed ID: 19384158
[TBL] [Abstract][Full Text] [Related]
62. Regulatory T Cells in Chronic Graft-Versus-Host Disease After Extracorporeal Photopheresis: Correlation With Skin and Global Organ Responses, and Ability to Taper Steroids.
Denney HA; Whittle RJ; Lai J; Jacques RM; Taylor PC
Transplantation; 2017 Jan; 101(1):204-211. PubMed ID: 27007227
[TBL] [Abstract][Full Text] [Related]
63. Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010-2015.
Ling YL; Huang X; Mitri G; Lovelace B; Pham A; Knobler R; Li X; Gao X
J Dermatolog Treat; 2020 Feb; 31(1):91-98. PubMed ID: 30892982
[No Abstract] [Full Text] [Related]
64. Cryopreservation of mononuclear cells before extracorporeal photochemotherapy does not impair their anti-proliferative capabilities.
Merlin E; Hannani D; Veyrat-Masson R; Chassagne J; Gabert F; Berger M; Deméocq F; Plumas J; Kanold J
Cytotherapy; 2011 Feb; 13(2):248-55. PubMed ID: 20662606
[TBL] [Abstract][Full Text] [Related]
65. Modulation of lymphocyte subpopulations by extracorporeal photopheresis in patients with acute graft-versus-host disease or graft rejection.
Lorenz K; Rommel K; Mani J; Jin N; Hilgendorf I; Ho AD; Freund M; Schmitt M; Schmitt A
Leuk Lymphoma; 2015 Mar; 56(3):671-5. PubMed ID: 24913503
[TBL] [Abstract][Full Text] [Related]
66. Extracorporeal photopheresis as a therapy for autoimmune diseases.
Kuzmina Z; Stroncek D; Pavletic SZ
J Clin Apher; 2015 Aug; 30(4):224-37. PubMed ID: 25546289
[TBL] [Abstract][Full Text] [Related]
67. Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells.
Gatza E; Rogers CE; Clouthier SG; Lowler KP; Tawara I; Liu C; Reddy P; Ferrara JL
Blood; 2008 Aug; 112(4):1515-21. PubMed ID: 18411417
[TBL] [Abstract][Full Text] [Related]
68. Extracorporeal photophoresis augments function of CD4+CD25+FoxP3+ regulatory T cells by triggering adenosine production.
Schmitt S; Johnson TS; Karakhanova S; Näher H; Mahnke K; Enk AH
Transplantation; 2009 Aug; 88(3):411-6. PubMed ID: 19667946
[TBL] [Abstract][Full Text] [Related]
69. Photopheresis in cutaneous T-cell lymphoma: five-year experience.
Crovetti G; Carabelli A; Berti E; Guizzardi M; Fossati S; De Filippo C; Bertani E
Int J Artif Organs; 2000 Jan; 23(1):55-62. PubMed ID: 12118838
[TBL] [Abstract][Full Text] [Related]
70. Single-center experience with extracorporeal photopheresis in pediatric heart transplantation.
Carlo WF; Pearce FB; George JF; Tallaj JA; McGiffin DC; Marques MB; Adamski J; Kirklin JK
J Heart Lung Transplant; 2014 Jun; 33(6):624-8. PubMed ID: 24661684
[TBL] [Abstract][Full Text] [Related]
71. Shaping of CD56
Ni M; Wang L; Yang M; Neuber B; Sellner L; Hückelhoven-Krauss A; Schubert ML; Luft T; Hegenbart U; Schönland S; Wuchter P; Chen BA; Eckstein V; Krüger W; Yerushalmi R; Beider K; Nagler A; Müller-Tidow C; Dreger P; Schmitt M; Schmitt A
Front Immunol; 2019; 10():547. PubMed ID: 30949182
[TBL] [Abstract][Full Text] [Related]
72. Assessment of 8-methoxypsoralen and ultraviolet a light effects on human stroma generation and function.
Legitimo A; Consolini R; Bencivelli W; Crimaldi G; Migliaccio P; Mosca F
Acta Haematol; 2006; 116(3):192-7. PubMed ID: 17016038
[TBL] [Abstract][Full Text] [Related]
73. Application of extracorporeal photopheresis in kidney transplant recipients: technical considerations and procedure tolerance.
Kusztal M; Kłak R; Krajewska M; Boratyńska M; Patrzałek D; Klinger M
Transplant Proc; 2011 Oct; 43(8):2941-2. PubMed ID: 21996195
[TBL] [Abstract][Full Text] [Related]
74. The use of extracorporeal photopheresis for allograft rejection in liver transplant recipients.
Urbani L; Mazzoni A; Catalano G; De Simone P; Vanacore R; Pardi C; Bortoli M; Biancofiore G; Campani D; Perrone V; Mosca F; Scatena F; Filipponi F
Transplant Proc; 2004 Dec; 36(10):3068-70. PubMed ID: 15686696
[TBL] [Abstract][Full Text] [Related]
75. Extracorporeal photopheresis--a new approach for the treatment of cutaneous T cell lymphomas.
Gollnick HP; Owsianowski M; Ramaker J; Chun SC; Orfanos CE
Recent Results Cancer Res; 1995; 139():409-15. PubMed ID: 7597308
[TBL] [Abstract][Full Text] [Related]
76. Long-term follow-up and survival of cutaneous T-cell lymphoma patients treated with extracorporeal photopheresis.
Knobler R; Duvic M; Querfeld C; Straus D; Horwitz S; Zain J; Foss F; Kuzel T; Campbell K; Geskin L
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):250-7. PubMed ID: 22971190
[TBL] [Abstract][Full Text] [Related]
77. A Prospective Trial of Extracorporeal Photopheresis for Chronic Graft-versus-Host Disease Reveals Significant Disease Response and No Association with Frequency of Regulatory T Cells.
Gandelman JS; Song DJ; Chen H; Engelhardt BG; Chen YB; Clark WB; Giver CR; Waller EK; Jung DK; Jagasia M
Biol Blood Marrow Transplant; 2018 Dec; 24(12):2373-2380. PubMed ID: 29981848
[TBL] [Abstract][Full Text] [Related]
78. Development of iron deficiency anemia in patients undergoing extracorporeal photopheresis: Comparison of the UVAR and CELLEX instruments.
Moosavi MM; Goodman AL; Duncan A; Stowell SR; Waller EK; Roback JD; Sullivan HC
J Clin Apher; 2021 Feb; 36(1):34-40. PubMed ID: 32894888
[TBL] [Abstract][Full Text] [Related]
79. [Extracorporeal photopheresis].
Hsieh A; Cortés B
Rev Med Suisse; 2018 Mar; 14(600):699-702. PubMed ID: 29589657
[TBL] [Abstract][Full Text] [Related]
80. Automated mononuclear cell collection: a feasibility study employing a new software for extracorporeal photopheresis.
Del Fante C; Scudeller L; Mortellaro C; Viarengo G; Martinasso A; Perotti C
Vox Sang; 2019 Nov; 114(8):884-889. PubMed ID: 31463961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
